Biogen Idec Inc.

NAS : BIIB
Pharmaceuticals
Weston MA
IW Best50N/A
2012 Revenue (US$ Millions)$4,379
2011 Revenue (US$ Millions)$4,052
Revenue Growth (%)8.06%
Net Income (US$ Millions)$1,380
Common Shares Outstanding (Millions)$237
Earnings Per Share (US$)$5.76
Total Equity (US$ Millions)$6,962
Profit Growth (%)11.8
Profit Margin (%)31.52%
Return On Equity (%)21.48%
Long Term Debt (US$ Millions)$687
Debt To Equity Ratio (%)0.10%
Market Capitalization (US$ Millions)$34,629
Total Assets (US$ Millions)$10,130
Return on Assets (%)15.25
Current Assets (US$ Millions)$3,244
Inventories (US$ Millions)$447
Current Liabilities (US$ Millions)$1,657
Cost of Goods Sold (US$ Millions)$545
Asset Turnover0.43
Inventory Turnover1.41